Los Angeles, CA -- (SBWIRE) -- 01/19/2019 -- Amlodipine is a calcium channel blocker. It works by relaxing the muscles of your heart and blood vessels. Olmesartan is an angiotensin II receptor antagonist. Olmesartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. The combination of amlodipine and olmesartan is used to treat high blood pressure (hypertension).

This report focuses on the global Amlodipine and Olmesartan status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amlodipine and Olmesartan development in United States, Europe and China.

The key players covered in this study

Daiichi Sankyo

Teva

Glenmark Pharmaceuticals

Matrix Laboratories

Torrent Pharmaceuticals

Aurobindo

Macleods Pharmaceuticals

Alembic Pharmaceuticals

Ajanta Pharma

Jubilant Pharma

Accord Healthcare

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/925880/global-amlodipine-and-olmesartan-market

Market segment by Type, the product can be split into

5/20 mg Tablets

10/20 mg Tablets

5/40 mg Tablets

10/40 mg Tablets

Market segment by Application, split into

Hospital

Drug store

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/925880/global-amlodipine-and-olmesartan-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.